Jill Massey

Jill Massey is an accomplished pharmaceutical executive with extensive experience in medical affairs, safety, and pharmacovigilance. Currently serving as Vice President of Global Medical Strategic Operations at Gilead Sciences since April 2021, Jill previously held key leadership positions at Immunomedics, Melinta Therapeutics, The Medicines Company, Johnson & Johnson, and Bristol-Myers Squibb. With a strong background in strategic development and governance within medical communications and services, Jill has effectively improved patient outcomes through impactful data generation and external collaborations. Educational qualifications include a PharmD from the University of Nebraska Medical Center, an MBA from Drexel University's LeBow College of Business, and multiple certifications, underscoring a solid foundation in pharmaceutical sciences and business management.